Dr Reddy’s announces commercialisation of Vozet in India

Hyderabad, July 18 (IANS) Pharma major Dr Reddy's Laboratories on Tuesday announced the commercialisation of Vozet tablets in India, used for the treatment of allergic Rhinitis and chronic Urticaria.

The Vozet tablets contain Levocetirizine 5 mg, and are available in a strip size of 10, the Hyderabad-headquartered company said in a statement.

The anti-histamine market in India had sales of Rs 1,038 crore MAT (Moving Annual Total) for the most recent 12 months ended March 2017, according to information technology company for the healthcare industry IMS ORG.

Dr Reddy's will further strengthen its anti-allergy portfolio with the addition of Vozet, said the statement.

(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)

Facebook Comments

About VDC

Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.

Share

This website uses cookies.

%%footer%%